Navigation Links
Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Date:9/3/2009

AURORA, Ontario, Sept. 3 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today announced that John Docherty, president and chief operating officer, will present at the Rodman and Renshaw 11th Annual Healthcare Conference at 12:05 p.m. EDT on Wednesday, Sept. 9, at the New York Palace Hotel in New York. Mr. Docherty will provide an overview of the Company's leading product development programs L-DOS47 and Topical Interferon Alpha-2b. The slide show portion of the presentation will be posted on the Company's website, www.helixbiopharma.com, on September 9th, 2009.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is listed on the TSX and FSE under the symbol "HBP" and on the OTCQX International Market under the symbol "HXBPF".

For further information contact:

    Investor & Media Relations
    Robert Flamm, Ph.D.                        Ian Stone
    Russo Partners LLC                         Russo Partners LLC
    Tel: (212) 845-4226                        Tel: (619) 814-3510
    Email: robert.flamm@russopartnersllc.com   Fax: (619) 955-5318
    www.russopartnersllc.com                   Email:
                                               ian.stone@russopartnersllc.com

This News Release contains certain forward-looking statemen
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses
2. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
3. Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
4. Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
5. Helix BioPharma to Present at the BioFinance 2009 Conference
6. Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division
7. Helix BioPharma Announces Q2 2009 Financial Results
8. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
9. Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
10. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
11. Helix BioPharma Announces Q1 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... electric cars could be on roads across North America before ... by the United States Department of Energy, Los Alamos National ... is part of a team led by the Los Alamos ... expensive platinum catalysts in fuel cells. , "One of the ... is the cost of the units. The pure platinum needed ...
(Date:6/18/2013)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the fourth quarter and full year of ... Fourth Quarter of Fiscal 2013 Highlights , ... by 33.3% to RMB133.0 million ($21.4 million) from RMB99.8 ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 In support ... sustainability, the Consulate General of Switzerland in New York ... Switzerland’s MS Tûranor PlanetSolar , to Manhattan. ... its DeepWater Expedition 2013 tour with scientists on board ... Capitain Gérard d’Aboville, runs exclusively on energy from the ...
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
Breaking Biology Technology:US and Canadian researchers drive towards cheaper fuel cells for electric cars 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4ExakTime Introduces AccountLinx Plus 2
... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... and stem cell research systems, today announced positive ... These validation results were presented today by ... University of Pittsburgh School of Medicine as ...
... Calif., Feb. 25 Cord Blood America, Inc. ... stem cell preservation company ( http://www.cordblood-america.com ) focused ... cells to families nationwide and internationally, today announced ... restructure its current outstanding debt."The restructuring is a ...
... development of CureDM,s HIP2B peptide targeted for the treatment of type 1 ... ... 2009 -- Calvert Research, LLC (a Calvert Holdings, Inc. ... CureDM to continue the preclinical development of CureDM,s HIP2B peptide. Calvert ...
Cached Biology Technology:Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 2Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 3Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 4Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 5Cord Blood America Restructures Debt; Projects to be Cash Flow Positive 2Calvert Research and CureDM Sign Collaborative Agreement 2Calvert Research and CureDM Sign Collaborative Agreement 3
(Date:6/16/2013)... FRANCISCO (June 16, 2013)Male mice who were fed a ... father offspring who also had higher levels of body ... effect was observed primarily in male offspring, despite their ... the annual meeting of The Endocrine Society in San ... that may affect metabolism and behavior of offspring dependent ...
(Date:6/16/2013)... years ago triggered a similar marine ecosystem crisis to ... global warming, according to research published today in ... the universities of Newcastle, UK, Cologne, Frankfurt and GEOMAR-Kiel, ... in the marine ecosystem during the mid-Cretaceous greenhouse period. ... the amplitude and duration of the temperature change.,Analysing the ...
(Date:6/14/2013)... Many students have difficulty understanding and explaining how ... teach the subject, researchers at Michigan State University ... from the molecular changes underlying an evolving characteristic ... The researchers, Peter J. T. White, Merle K. ... of the scenarios into a cellular and molecular ...
Breaking Biology News(10 mins):Obese male mice father offspring with higher levels of body fat 2Global cooling as significant as global warming 2Teaching complete evolutionary stories increases learning 2
... cancers account for more than 1 million deaths worldwide ... to identify the molecular events that result in the ... established that interfering with the function of one gene, ... on the cells lining the innermost layer of the ...
... research study identifies a critical inhibitory step that ... regulating the balance between neutrophil production and destruction. ... Immunity, suggests that the process for disposal of ... A clear understanding of the processes that control ...
... disease in which cells in the bone marrow grow and ... (leukemic). The progression of the disease is slow and there ... production of CLL cells, and the time-course of their death. ... a static disease of long-lived lymphocytes -- that the leukemia ...
Cached Biology News:Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer 2White blood cell waste disposal system plays critical regulatory role 2The very unexpected life and death of a leukemic cell 2